ATRA
Atara Biotherapeutics, Inc.
0.61
USD
This page is just a preview of the data found in TrendSpider’s full version
Atara Biotherapeutics, Inc. stock is down -52.48% since 30 days ago. The next earnings date is Feb 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 80% of the previous 9 November’s closed higher than October. In the last 2 Unusual Options Trades, there were 2 PUTs. 0% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 10 Oct 17:34 | 17 Nov, 2023 | 2.50 | 715 | ||
| 01 Nov 14:21 | 17 Nov, 2023 | 2.50 | 1018 |
Atara Biotherapeutics, Inc. develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
